FDA found Listeria monocytogenes in Chang and Son's mung bean and soybean sprout operation and in its sprouts.
What happened
Massachusetts agriculture officials collected 15 swab samples from surfaces in the company's sprouting operation in Whately, MA, on December 20, 2023, and two were positive for Listeria monocytogenes. Whole genome sequencing (DNA fingerprinting of the bacteria) showed those isolates matched each other and 10 Listeria found in three mung bean sprout samples collected at retail and at the plant between April 2023 and December 2023. FDA then inspected the operation from January 10 to February 8, 2024, collecting 91 environmental swabs, one of which (from a truck bed outside) was positive.
What FDA found
Sprouts were prepared, packed or held under insanitary conditions that could make them harmful to health, because Listeria monocytogenes was present in the plant environment.
section 402(a)(4) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 342(a)(4)Mung bean sprouts contained Listeria monocytogenes, a substance that can make the food injurious to health.
section 402(a)(1) of the Act, 21 U.S.C. § 342(a)(1)The company's own records never found Listeria in its environment even though FDA and state testing did, so FDA said its sanitation efforts were not adequate to control the pathogen.
21 CFR Part 112 (Produce Safety Rule)
What FDA wants
FDA tells the company to reply in writing within 15 working days describing each corrective step taken, how recurrence will be prevented, and copies of supporting records, and to review its Listeria monitoring plan and its cleaning frequency and methods. FDA says it will check whether the corrections are adequate at the next inspection.
Who should pay attention
- retailers and distributors that sell fresh sprouts
- brands and food service buyers sourcing sprouts from this grower
- produce safety and supplier verification teams at grocery chains
This is a summary. Read the original letter on fda.gov.